| Intravenous Immunoglobulin (IVIG) |
0 |
1 |
| Dermatitis |
0 |
0.62 |
| Dermatomyositis |
0 |
0.99 |
| Immunoglobulin A (IgA) |
0 |
0.6 |
| Intravenous |
0 |
0.5 |
| Hypertension |
0 |
0.14 |
| Id Reaction |
0 |
0.14 |
| Muscle |
0 |
0.14 |
| Pain Management |
0 |
0.14 |
| Renal Failure |
0 |
0.14 |
| Thrombocytopenia |
0 |
0.14 |
| Thromboembolism |
0 |
0.14 |
| Idiopathic Thrombocytopenic Purpura |
0 |
0.1 |
| Increased Blood Pressure |
0 |
0.1 |
| Headache |
0 |
0.08 |
| Acute Kidney Injury |
0 |
0.07 |
| Arthritis |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Child |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Dyspnea |
0 |
0.07 |
| Emesis |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.75 |
| Heart |
0 |
0.07 |
| Myositis |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Skin Rash |
0 |
0.07 |
| Thrombocytopenic Purpura |
0 |
0.07 |
| Thrombosis |
0 |
0.07 |
| Weakness |
0 |
0.07 |